ReviewFrontiers in bioengineering and biotechnology2025
The sculpting tool in bioprinting: research and application progress of sacrificial inks.
Review in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Support-Enabled 3D Printing of Complex Anisotropic Hydrogel Structures Using Cellulose-Based Inks: Pathways Toward Biomimetic Human Aorta Models.ACS biomaterials science & engineering · 2026Article
- Construction, evaluation, and applications of renal barrier-on-a-chip system.Bioactive materials · 2026Review
- Bioprinting of Microtissues Within Mechanically Tunable Support Baths to Engineer Anisotropic Musculoskeletal Tissues.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The core of bio-3D printing technology lies in the development and optimization of bio-inks. For a long time, researchers have been looking for bio-inks that can balance printability and cell function. However, traditional bio-inks often have limitations in meeting this balance, limiting the complexity and scale of printable structures. In recent years, the emergence of sacrificial inks has brought a major breakthrough in this field, allowing bio-inks that were originally not very suitable for printing to accurately construct larger and more complex structures. This ink is unique in that it is used to support and position the bio-ink but is removed after printing is complete, not as part of the final printed structure. The mild nature of the state transition and removal conditions allows for minimal damage to cell viability and print structure when the ink is "sacrificed." This review will focus on the types of sacrificial inks and their two key applications in bioprinting: building intracranial vascular networks and improving bioink performance. We will summarize the current status, advantages, and challenges of these applications, aiming to provide readers with a comprehensive overview of the latest advances in the use of sacrificial inks in bioprinting. By sacrificing the application of ink, bioprinting technology can not only produce more realistic and complex tissue structures but also is expected to provide broader application prospects for clinical treatment and regenerative medicine in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.